Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trialZoltán Bánki, Janine Kimpel, Annika Rössler et al.|EBioMedicine|2022Cited by 38